NOV 20, 2015 4:57 PM PST

Alcoholism Drug Brings Out Dormant HIV-Infected Cells - So That It Can Be Destroyed

WRITTEN BY: Julianne Chiaet

A new use of an old drug might be the "game changer” researchers were looking for in their quest to cure HIV.

Disulfiram, a drug used to treat alcoholism, drags latent HIV out of hiding, without any harmful side-effects. Once dragged out, the virus can be targeted and destroyed. The discovery is an important step towards tackling HIV latency. HIV latency allows the virus to integrate into the DNA of the host cell and avoid the immune system. While the latent virus doesn't usually cause symptoms, doctors still need to destroy it. Unfortunately, it is nearly impossible to target and remove the latent virus from the cell without destroying the cell itself.
 
 
Researchers have come one step closer to eradicating HIV.


Scientists have found drugs in the past that draw the virus out. Those drugs, however, induce too many toxic side-effects to be considered an option for treatment. 

Infectious disease scientist Sharon Lewin led a team of international researchers in a quest to find a non-toxic drug capable of activating HIV in the body. The findings were published in The Lancet on November 16, 2015. 

Researchers in Melbourne and San Francisco gave Disulfiram to 30 HIV positive participants in progressively higher doses for three days. The first two dosages, 500mg and 1000mg, did not produce a measured effect. The third dose, 2000 mg, drew the dormant virus out. On day 10, the amount of virus RNA in the participant's blood plasma increased by 70 percent. On day 30, the amount increased to 100 percent.

Unlike the other drugs, no serious side effects were recorded.

Researchers now need to figure out how the drug reacts in combination with other HIV therapies, and how will it affect patients who take the drug over a longer period of time. 

While there are still unanswered questions, Disulfiram has the potential to help the 35 million people living with HIV today. 


Sources: The Lancet, The University of Melbourne via The Melbourne NewsroomWHO, ScienceAlert
 
About the Author
  • Julianne (@JuliChiaet) covers health and medicine for LabRoots. Her work has been published in The Daily Beast, Scientific American, and MailOnline. While primarily a science journalist, she has also covered culture and Japanese organized crime. She is the New York Board Representative for the Asian American Journalists Association (AAJA). • To read more of her writing, or to send her a message, go to Jchiaet.com
You May Also Like
JAN 14, 2020
Genetics & Genomics
JAN 14, 2020
Genetic Study Reveals Drug Targets for Several Diseases
Some genetic mutations are due to a change in only one base of the genetic code, while others involve large regions of the genome....
JAN 24, 2020
Immunology
JAN 24, 2020
Immune "Recycling" Could Improve Cancer Immunotherapy
A natural housekeeping function performed by many cells of the human body, including those in the immune system, is under intense scrutiny for its potentia...
JAN 29, 2020
Health & Medicine
JAN 29, 2020
Feeling Bloated? A High-Fiber, Protein-Rich Diet May be to Blame
Did your new year’s resolution include opting for a healthier diet? When making changes to your diet, it’s important to be aware of possible si...
JAN 30, 2020
Microbiology
JAN 30, 2020
25% of Antibiotic-Resistant Bacteria Can Spread Resistance Directly to Other Microbes
This research also suggests that antibiotics do not increase the rate at which bacteria acquire drug resistance genes....
FEB 11, 2020
Cannabis Sciences
FEB 11, 2020
Understanding THC Content in Cannabis Edibles
Nearly one-third of cannabis users in Canada consume edible cannabis products, according to a 2018 Statistics Canada report. But do people who use edible c...
FEB 12, 2020
Health & Medicine
FEB 12, 2020
Brain Patients are Advancing Research
Neuroscientists may face the challenge of not having enough material or high-quality material to study the condition they’re researching. Luckily&mda...
Loading Comments...